Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Almut Scherer

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Annals of the Rheumatic Diseases|December 21, 2013
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort studyBurkhard Möller, Menno Pruijm, Sabine Adler, et al.
Rheumatology (Oxford, England)|April 13, 2021
Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factorsSimone Arnold, Veronika K Jaeger, Almut Scherer, et al.
Joint Bone Spine|November 12, 2013
Ultrasound evaluation of synovitis in RA: correlation with clinical disease activity and sensitivity to change in an observational cohort studyPascal Zufferey, Laure Brulhart, Giorgio Tamborrini, et al.
Joint Bone Spine|June 25, 2014
Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort studyPascal Zufferey, Burkhard Möller, Laure Brulhart, et al.
Joint Bone Spine|November 21, 2012
BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatmentFabienne Niederer, Almut Scherer, Diego Kyburz, et al.
Clinical Rheumatology|April 23, 2017
Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtypingDaniel Stekhoven, Almut Scherer, Michael J Nissen, et al.
Arthritis Research & Therapy|March 23, 2016
Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management CohortAdrian Ciurea, Pascale Exer, Ulrich Weber, et al.
Plos One|June 29, 2021
Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural networkMaria Kalweit, Ulrich A Walker, Axel Finckh, et al.
Rheumatology (Oxford, England)|August 19, 2010
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletionUlrich A Walker, Delphine S Courvoisier, Jean Dudler, et al.
Arthritis Research & Therapy|October 10, 2020
Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohortRegula Neuenschwander, Monika Hebeisen, Raphael Micheroli, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Annals of the Rheumatic Diseases|December 21, 2013
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort studyBurkhard Möller, Menno Pruijm, Sabine Adler, et al.
Rheumatology (Oxford, England)|April 13, 2021
Discontinuation of biologic DMARDs in a real-world population of patients with rheumatoid arthritis in remission: outcome and risk factorsSimone Arnold, Veronika K Jaeger, Almut Scherer, et al.
Joint Bone Spine|November 12, 2013
Ultrasound evaluation of synovitis in RA: correlation with clinical disease activity and sensitivity to change in an observational cohort studyPascal Zufferey, Laure Brulhart, Giorgio Tamborrini, et al.
Joint Bone Spine|June 25, 2014
Persistence of ultrasound synovitis in patients with rheumatoid arthritis fulfilling the DAS28 and/or the new ACR/EULAR RA remission definitions: results of an observational cohort studyPascal Zufferey, Burkhard Möller, Laure Brulhart, et al.
Joint Bone Spine|November 21, 2012
BAFF levels in patients with ankylosing spondylitis and response to anti-tumor necrosis factor treatmentFabienne Niederer, Almut Scherer, Diego Kyburz, et al.
Clinical Rheumatology|April 23, 2017
Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtypingDaniel Stekhoven, Almut Scherer, Michael J Nissen, et al.
Arthritis Research & Therapy|March 23, 2016
Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management CohortAdrian Ciurea, Pascale Exer, Ulrich Weber, et al.
Plos One|June 29, 2021
Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural networkMaria Kalweit, Ulrich A Walker, Axel Finckh, et al.
Rheumatology (Oxford, England)|August 19, 2010
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletionUlrich A Walker, Delphine S Courvoisier, Jean Dudler, et al.
Arthritis Research & Therapy|October 10, 2020
Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohortRegula Neuenschwander, Monika Hebeisen, Raphael Micheroli, et al.
Pageof 6